NCT02668952View on ClinicalTrials.gov

Fluid Chloride and AKI in Cardiopulmonary Bypass

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 4, 2017

Study Completion Date

February 28, 2018

Conditions
Acute Kidney Injury
Interventions
DRUG

0.9% Normal Saline (0.9% Sodium Chloride) injection

DRUG

Isolyte S injection

Trial Locations (1)

87106

University of New Mexico Hospital, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT02668952 - Fluid Chloride and AKI in Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter